longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HUALAN BIOLOGICAL

002007

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: HUALAN BIOLOGICAL(002007) the Revenue is 804.53 M (-13.55%), Miss estimate;the EBIT is 192.84 M (-18.86%), Miss estimate;the EPS is 0.08 (-27.27%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.80B13.55%
0.85B8.36%
-0.05B5.19%
EBITMiss expectations
0.19B18.86%
0.22B8.04%
-0.03B10.82%
EPSMiss expectations
0.0827.27%
0.11--
-0.030027.27%

Revenue

ActualEstimateUnit: CNY
qf

EBIT

ActualEstimateUnit: CNY
qf

Net income

ActualEstimateUnit: CNY
qf

EPS

ActualEstimateUnit: CNY
qf